Cargando…
Spinal muscular atrophy: from tissue specificity to therapeutic strategies
Spinal muscular atrophy (SMA) is the most frequent genetic cause of death in infants and toddlers. All cases of spinal muscular atrophy result from reductions in levels of the survival motor neuron (SMN) protein, and so SMN upregulation is a focus of many preclinical and clinical studies. We examine...
Autores principales: | Iascone, Daniel M., Henderson, Christopher E., Lee, Justin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311279/ https://www.ncbi.nlm.nih.gov/pubmed/25705387 http://dx.doi.org/10.12703/P7-04 |
Ejemplares similares
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017) -
Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018) -
Spinal muscular atrophy disease: a literature review for therapeutic strategies
por: Stavarachi, M, et al.
Publicado: (2010) -
Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011) -
Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy
por: Banno, Haruhiko, et al.
Publicado: (2009)